These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16625699)

  • 21. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.
    Galvani AP; Novembre J
    Microbes Infect; 2005 Feb; 7(2):302-9. PubMed ID: 15715976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of CCR5 variants among rural populations with low HIV-1 prevalence in Cameroon.
    Torimiro JN; Wolfe ND; Thomas A; Martin MP; Mpoudi-Ngole E; Tamoufe U; Birx DL; Carrington M; Burke DS; Carr JK
    AIDS; 2007 Feb; 21(4):527-8. PubMed ID: 17301575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of CCR2-64I, SDF1-3'A and CCR5-Delta32 alleles in healthy Thais.
    Nookhai S; Ruxrungtham K; Phanuphak P; Oelrichs R
    Eur J Immunogenet; 2000 Jun; 27(3):153-7. PubMed ID: 10940085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCR5-Delta32 allele frequencies in Ashkenazi Jews.
    Lucotte G; Smets P
    Genet Test; 2003; 7(4):333-7. PubMed ID: 15000812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of the CCR5-delta 32 chemokine receptor gene mutation in the Lebanese population.
    Karam W; Jurjus R; Khoury N; Khansa H; Assad C; Zalloua P; Jurjus A
    East Mediterr Health J; 2004; 10(4-5):671-5. PubMed ID: 16335661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of CCR5 Gene 32-bp deletion in Pakistani ethnic groups.
    Khaliq S; Hameed A; Ayub Q; Mazhar K; Mohyuddin A; Mansoor A; Mehdi SQ
    Genet Test; 2002; 6(2):123-7. PubMed ID: 12215252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of the CCR5 delta32 allele in Italian HIV type 1-infected and normal individuals.
    Battiloro E; Andreoni M; Parisi SG; Mura MS; Sotgiu G; Aceti A; Cossu G; Concia E; Verna R; D'Ambrosio E
    AIDS Res Hum Retroviruses; 2000 Jan; 16(2):181-2. PubMed ID: 10659057
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV-1 co-receptor CCR5 and CCR2 mutations among Greeks.
    Papa A; Papadimitriou E; Adwan G; Clewley JP; Malissiovas N; Ntoutsos I; Alexiou S; Antoniadis A
    FEMS Immunol Med Microbiol; 2000 May; 28(1):87-9. PubMed ID: 10767612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms of CCR5 gene in a southern Chinese population and their effects on disease progression in HIV infections.
    Zheng BJ; Zhao XY; Zhu NS; Chan CP; Wong KH; Chan KC; Yam WC; Yuen KY; Lee SS
    AIDS; 2002 Dec; 16(18):2480-2. PubMed ID: 12461425
    [No Abstract]   [Full Text] [Related]  

  • 31. CCR5, vertical transmission of HIV-1, and disease progression. European Collaborative Study.
    Bailey AJ; Newell ML; De Rossi A; Giaquinto C; Iasci A; Ravizza M; Garcia-Rodriguez MC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):211-2. PubMed ID: 10048913
    [No Abstract]   [Full Text] [Related]  

  • 32. Historic exposure to plague and present-day frequency of CCR5del32 in two isolated island communities of Dalmatia, Croatia.
    Smoljanović M; Ristić S; Hayward C
    Croat Med J; 2006 Aug; 47(4):579-84. PubMed ID: 16909455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection.
    Grimaldi R; Shindo N; Acosta AX; Dourado I; Brites C; de Melo Carvalho O; Brito I; Bou-Habib DC; Galvão-Castro B
    Hum Genet; 2002 Jul; 111(1):102-4. PubMed ID: 12136242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic effects on HIV disease progression.
    Ioannidis JP; O'Brien TR; Rosenberg PS; Contopoulos-Ioannidis DG; Goedert JJ
    Nat Med; 1998 May; 4(5):536. PubMed ID: 9585207
    [No Abstract]   [Full Text] [Related]  

  • 35. Could FIV zoonosis responsible of the breakdown of the pathocenosis which has reduced the European CCR5-Delta32 allele frequencies?
    Faure E
    Virol J; 2008 Oct; 5():119. PubMed ID: 18925940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients.
    Guérin S; Meyer L; Theodorou I; Boufassa F; Magierowska M; Goujard C; Rouzioux C; Debré P; Delfraissy JF;
    AIDS; 2000 Dec; 14(17):2788-90. PubMed ID: 11125899
    [No Abstract]   [Full Text] [Related]  

  • 37. Frequency analysis of the delta32ccr5 HIV resistance allele in a medieval plague mass grave.
    Kremeyer B; Hummel S; Herrmann B
    Anthropol Anz; 2005 Mar; 63(1):13-22. PubMed ID: 15830584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection.
    Romiti ML; Colognesi C; Cancrini C; Mas A; Berrino M; Salvatori F; Orlandi P; Jansson M; Palomba E; Plebani A; Bertran JM; Hernandez M; de Martino M; Amoroso A; Tovo PA; Rossi P; Espanol T; Scarlatti G
    Mol Med; 2000 Jan; 6(1):28-36. PubMed ID: 10803406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of CCR5 and SDF-1 genetic variants and HIV infection in Indian population.
    Gupta A; Padh H
    Int J Immunogenet; 2015 Aug; 42(4):270-8. PubMed ID: 26096543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Ground truth" for selection on CCR5-Delta32.
    Hedrick PW; Verrelli BC
    Trends Genet; 2006 Jun; 22(6):293-6. PubMed ID: 16678299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.